Natco Pharma informs about company updates

10 May 2017 Evaluate

Natco Pharma has informed about Natco launches Pomalid, first generic version of pomalidomide capsules, for treatment of a specific blood cancer, in India.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1032.30 3.10 (0.30%)
28-May-2024 15:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.